These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition. Fleischman AG, Maxson JE, Luty SB, Agarwal A, Royer LR, Abel ML, MacManiman JD, Loriaux MM, Druker BJ, Tyner JW. Blood; 2013 Nov 21; 122(22):3628-31. PubMed ID: 24081659 [Abstract] [Full Text] [Related]
10. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia. Ouyang Y, Qiao C, Chen Y, Zhang SJ. Oncotarget; 2017 Mar 28; 8(13):20834-20841. PubMed ID: 28209919 [Abstract] [Full Text] [Related]
11. Genomics of chronic neutrophilic leukemia. Maxson JE, Tyner JW. Blood; 2017 Feb 09; 129(6):715-722. PubMed ID: 28028025 [Abstract] [Full Text] [Related]
12. Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia. Adam FC, Szybinski J, Halter JP, Cantoni N, Wenzel F, Leonards K, Brkic S, Passweg JR, Touw I, Maxson JE, Meyer SC. Curr Oncol; 2022 Feb 01; 29(2):805-815. PubMed ID: 35200567 [Abstract] [Full Text] [Related]
13. What's different about atypical CML and chronic neutrophilic leukemia? Dao KH, Tyner JW. Hematology Am Soc Hematol Educ Program; 2015 Feb 01; 2015():264-71. PubMed ID: 26637732 [Abstract] [Full Text] [Related]
14. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes. Carreño-Tarragona G, Álvarez-Larrán A, Harrison C, Martínez-Ávila JC, Hernández-Boluda JC, Ferrer-Marín F, Radia DH, Mora E, Francis S, González-Martínez T, Goddard K, Pérez-Encinas M, Narayanan S, Raya JM, Singh V, Gutiérrez X, Toth P, Amat-Martínez P, Mcilwaine L, Alobaidi M, Mayani K, McGregor A, Stuckey R, Psaila B, Segura A, Alvares C, Davidson K, Osorio S, Cutting R, Sweeney CP, Rufián L, Moreno L, Cuenca I, Smith J, Morales ML, Gil-Manso R, Koutsavlis I, Wang L, Mead AJ, Rozman M, Martínez-López J, Ayala R, Cross NCP. Blood Adv; 2023 May 09; 7(9):1672-1681. PubMed ID: 36375042 [Abstract] [Full Text] [Related]
15. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. Maxson JE, Gotlib J, Pollyea DA, Fleischman AG, Agarwal A, Eide CA, Bottomly D, Wilmot B, McWeeney SK, Tognon CE, Pond JB, Collins RH, Goueli B, Oh ST, Deininger MW, Chang BH, Loriaux MM, Druker BJ, Tyner JW. N Engl J Med; 2013 May 09; 368(19):1781-90. PubMed ID: 23656643 [Abstract] [Full Text] [Related]
20. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia. Qian Y, Chen Y, Li X. Ann Hematol; 2021 Jun 09; 100(6):1459-1461. PubMed ID: 33822276 [Abstract] [Full Text] [Related] Page: [Next] [New Search]